Facebook
Twitter
LinkedIn
ForwardPrimary tabs
-
10/01/2023 - 12:00am to 09/30/2024 - 12:00am
-
01/29/2024 - 8:00am to 02/17/2024 - 11:59pmSession ObjectivesUpon completion of this activity learners should be able to:
-
01/29/2024 - 8:00am to 02/17/2024 - 11:59pmSession ObjectivesUpon completion of this activity learners should be able to:
-
02/05/2024 - 8:00am to 02/19/2024 - 11:59pmSession ObjectivesUpon completion of this activity learners should be able to:
-
02/05/2024 - 8:00am to 02/19/2024 - 11:59pmSession ObjectivesUpon completion of this activity learners should be able to:
-
02/08/2024 - 12:00pm to 02/29/2024 - 11:59pmOverarching objectives: Upon the completion of this session, learners should be able to:
-
02/08/2024 - 12:00pm to 02/29/2024 - 11:59pmUpon the completion of this activity, learners should be able to:
-
02/12/2024 - 8:00am to 02/26/2024 - 11:59pmSession ObjectivesUpon completion of this activity learners should be able to:
-
02/12/2024 - 8:00am to 02/26/2024 - 11:59pmSession ObjectivesUpon completion of this activity learners should be able to:
-
02/14/2024 - 8:00am to 02/15/2024 - 11:59pm
-
02/14/2024 - 8:00am to 02/15/2024 - 11:59pmSeries ObjectivesUpon completion of this activity leaners should be able to:
-
02/14/2024 - 12:00pm to 02/29/2024 - 11:59pmUpon completion of this activity leaners should be able to:
-
02/15/2024 - 7:00am to 02/16/2024 - 11:59pmSeries Learning ObjectivesUpon completion of this activity leaners should be able to:
-
02/15/2024 - 12:00pm to 02/29/2024 - 11:59pmOverarching objectives: Upon the completion of this session, learners should be able to:
-
02/15/2024 - 1:00pm to 02/16/2024 - 11:59pmSession Learning ObjectivesDiscuss indications for treatment with buprenorphine;Identify guidelines for buprenorphine induct